Oncology

  1. Polivy
    Polivy (polatuzumab vedotin-piiq)
    by Genentech, Inc
    for Lymphoma
    €0.00
  2. Inrebic
    Inrebic (fedratinib)
    by Impact Biomedicines, Inc.
    for Myelofibrosis
    €0.00
  3. Nubeqa
    Nubeqa (darolutamide)
    by Bayer HealthCare Pharmaceuticals Inc.
    for Prostate Cancer
    €0.00
  4. Tibsovo
    Tibsovo (ivosidenib)
    by Agios Pharmaceuticals, Inc.
    for Leukemia
    €34,213.00
  5. Piqray
    Piqray (alpelisib)
    by Novartis
    for Breast Cancer
    €23,736.00
  6. Rozlytrek
    Rozlytrek (entrectinib)
    by Genentech, Inc
    for Solid Tumor
    €10,214.98
  7. Balversa
    Balversa (erdafitinib)
    by Janssen Pharmaceutica
    for Urothelial Carcinoma
    €75,340.00
  8. Calquence
    Calquence (acalabrutinib)
    by AstraZeneca Pharmaceuticals LP
    for Lymphoma
    €20,427.96
  9. Libtayo
    Libtayo (cemiplimab)
    by Sanofi
    for Skin Cancer
    €3,147.60
View as Grid List

Items 1-9 of 49

Page
per page
Set Descending Direction